15 reports

  • 3.4.4 DIAGNOSED INCIDENT CASES OF PANCREATIC CANCER (EXCLUDING PNETS) BY CANCER STAGES AT DIAGNOSIS
  • 4.1 BIBLIOGRAPHY

Research Clinical Gastroenterology, ##(##), pp. ##-##. doi: ##. ##/ j. bpg. 2005. ##. ##.

  • Pancreatic Cancer
  • Japan
  • United States
  • World
  • Forecast
  • 11.1 BIBLIOGRAPHY
  • 5.4 FORECAST METHODOLOGY

AND YAMAGUCHI, T. (2014) ' S-## IN THE TREATMENT OF PANCREATIC CANCER. ', WORLD JOURNAL OF GASTROENTEROLOGY.

  • Pancreatic Cancer
  • AbbVie Inc.
  • AstraZeneca PLC
  • Halozyme Therapeutics, Inc.
  • Merck & Co., Inc.

Pancreatic cancer

4385 5000 3900
  • PRODUCT PROFILE (LATE STAGE): MOMELOTINIB

Gastroenterology, ##(##), ##-## < PMID> ##< / PMID>.

  • Pancreatic Cancer
  • Celgene Corporation
  • Gilead Sciences, Inc.
  • NewLink Genetics Corporation
  • Taiho Pharmaceutical Co., Ltd.

Lopez-Talavera was assistant professor with the Divisions of Gastroenterology and Hepatology, and Endocrinology and Pathology at the University of Pittsburgh Medical Center.

  • Clinical Trial
  • Pancreatic Cancer
  • Prostate Cancer
  • United States
  • AngioDynamics, Inc.
  • Large Number of Conferences

FIGURE ##.

  • Pancreatic Cancer
  • World
  • Forecast
  • Market Size
  • PharmaCyte Biotech, Inc.

The studies funded by the grant will be performed in collaboration with researchers at Cedars-Sinai Medical Center in Los Angeles, CA under the direction of the Chief of the Department of Gastroenterology, Dr.

  • Biopharmaceutical
  • Pancreatic Cancer
  • Therapy
  • United States
  • BioPharma company

The prominent features of this report are - ##.

  • Chemotherapy
  • Clinical Trial
  • Lung Cancer
  • Pancreatic Cancer
  • World
  • FEB 16, 2018: SPANISH CENTER SANTIAGO DE COMPOSTELA JOINS THE LARGEST EVER PROSPECTIVE STUDY INTO FAMILIAL RISK OF DEVELOPING PANCREATIC CANCER

THE FOLLOWING FINANCIAL TARGETS HAVE BEEN ESTABLISHED: THE TEAM AT THE DEPARTMENT OF GASTROENTEROLOGY AND HEPATOLOGY, UNIVERSITY HOSPITAL OF SANTIAGO DE COMPOSTELA IS LED BY PROFESSOR J ENRIQUE DOMÍNGUEZ-MUÑOZ, A WORLD LEADING AUTHORITY ON THE PANCREATIC FUNCTION, PANCREATIC DISEASES, AND P

  • Hospital
  • Pancreatic Cancer
  • United States
  • World
  • Product Initiative
  • Jul 17, 2017: Leading pancreatic cancer expert on early symptoms Professor Stephen Pereira at University College London joins Immunovia's Scientific Advisory Board

" The important prospective studies for the pancreas test within the diabetes group (" PANDIA-##) and the early symptoms group (" PANSYM-##) have in discussions with clinical partners made progress for both PANDIA-## and PANSYM-##.

  • Autoimmune Disease
  • Cancer
  • Pancreatic Cancer
  • Sweden
  • United States
  • Jul 17, 2017: Leading pancreatic cancer expert on early symptoms Professor Stephen Pereira at University College London joins Immunovia's Scientific Advisory Board

" The important prospective studies for the pancreas test within the diabetes group (" PANDIA-##) and the early symptoms group (" PANSYM-##) have in discussions with clinical partners made progress for both PANDIA-## and PANSYM-##.

  • Healthcare
  • Pancreatic Cancer
  • Pharmaceutical
  • Sweden
  • United States

The prominent features of this report are - ##.

  • Clinical Trial
  • Hepatitis
  • Pancreatic Cancer
  • Therapy
  • World
  • BIOMARKER TEST - PANCREATIC CANCER - PRODUCT DESCRIPTION
  • UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER PIPELINE PRODUCTS & ONGOING CLINICAL TRIALS OVERVIEW

CURRENTLY, PEREIRA IS PROFESSOR OF HEPATOLOGY & GASTROENTEROLOGY AT UCL, UNIVERSITY COLLEGE LONDON, AND AN HONORARY CONSULTANT IN PANCREATICOBILIARY MEDICINE AT UCL HOSPITALS AND THE ROYAL FREE HOSPITAL.

  • Biomarker
  • Cancer
  • Clinical Trial
  • Pancreatic Cancer
  • Proteome Sciences
  • PANCREATIC CANCER - PIPELINE BY ACTUATE THERAPEUTICS INC
  • BILE DUCT CANCER (CHOLANGIOCARCINOMA) - PIPELINE BY RAFAEL PHARMACEUTICALS INC

Its prescription products are used in the therapeutic areas of allergology and pulmonology, angiology, antibiotics treatment, diabetology, gastroenterology, gynecology, cardiology, neurology, ophthalmology, psychiatry, rheumatology urology, and others.

  • Cancer
  • Pancreatic Cancer
  • Pharmaceutical
  • Therapy
  • Product Initiative

It offers products across therapeutic areas such as, cardiology and metabolic, gastroenterology, respiratory, pneumology, infectious diseases, urology, rheumatology, osteoporosis, neurology and oncology.

  • Pancreatic Cancer
  • Pharmaceutical
  • United States
  • Product Initiative
  • Progen Pharmaceuticals Limited
  • FEATURED NEWS & PRESS RELEASES

Department of Gastroenterology GI Oncology Division, National Cancer Center Hospital East, Chiba, Japan; ##.

  • Cancer
  • Pancreatic Cancer
  • United States
  • Company
  • Product Initiative